@misc{indiciae45e3291ca790,
  title = {Combinatorial approaches using an AI/ML-driven drug development platform targeting insulin resistance, lipid dysregulation, and inflammation for the amelioration of metabolic syndrome in patients},
  author = {Khotimchenko, M. and Hixon, M. S. and Brunk, N. E. and Walden, D. M. and Hou, H. and Chakravarty, K. and Varshney, J.},
  year = {2021},
  doi = {10.1101/2021.09.01.458488},
  url = {https://www.biorxiv.org/content/10.1101/2021.09.01.458488v1},
  note = {Source identifier: 10.1101/2021.09.01.458488}
}